Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000769993-06-000023
Filing Date
2006-01-09
Accepted
2006-01-09 11:06:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G nabibiopharma.txt SC 13G 13148
  Complete submission text file 0000769993-06-000023.txt   15109
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Subject) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: SC 13G | Act: 34 | File No.: 005-31596 | Film No.: 06518212
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 32 OLD SLIP NEW YORK NY 10005
GOLDMAN SACHS ASSET MANAGEMENT LP (Filed by) CIK: 0001229262 (see all company filings)

EIN.: 000000000
Type: SC 13G